Tolazamide (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Tolazamide drug offered from Mylan Pharmaceuticals Inc.. This Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | tolazamide |
SUBSTANCE NAME: | TOLAZAMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2013-01-18 |
END MARKETING DATE: | 0000-00-00 |
Tolazamide HUMAN PRESCRIPTION DRUG Details:
Item Description | Tolazamide from Mylan Pharmaceuticals Inc. |
LABELER NAME: | Mylan Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 250(mg/1) |
START MARKETING DATE: | 2013-01-18 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0378-0217_e55c3303-e629-490e-b2f7-650b99099e74 |
PRODUCT NDC: | 0378-0217 |
APPLICATION NUMBER: | ANDA070259 |
Other TOLAZAMIDE Pharmaceutical Manufacturers / Labelers: